Cargando…
MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant
RATIONALE: Obliterative bronchiolitis (OB) is a significant cause of morbidity and mortality after lung transplant and hematopoietic cell transplant. Mesenchymal stromal cells (MSCs) have been shown to possess immunomodulatory properties in chronic inflammatory disease. OBJECTIVE: Administration of...
Autores principales: | Raza, Kashif, Larsen, Trevor, Samaratunga, Nath, Price, Andrew P., Meyer, Carolyn, Matson, Amy, Ehrhardt, Michael J., Fogas, Samuel, Tolar, Jakub, Hertz, Marshall I., Panoskaltsis-Mortari, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182803/ https://www.ncbi.nlm.nih.gov/pubmed/25272285 http://dx.doi.org/10.1371/journal.pone.0109034 |
Ejemplares similares
-
Obliterative Bronchiolitis
por: Silva, C. Isabela S., et al.
Publicado: (2008) -
Local C-Reactive Protein Expression in Obliterative Lesions and the Bronchial Wall in Posttransplant Obliterative Bronchiolitis
por: Päiväniemi, Outi E., et al.
Publicado: (2009) -
The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis
por: Hele, David J, et al.
Publicado: (2001) -
Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis
por: Andersson-Sjöland, Annika, et al.
Publicado: (2009) -
Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation
por: Nemska, Simona, et al.
Publicado: (2016)